https://doi.org/
Poster
NOT PEER REVIEWED
Download
metrics
VIEWS
317
 
downloads
158
CITE
How to cite this poster:
Le DT, Wang-Gillam A, Picozzi VJ et al. A phase 2b, randomized, controlled, multicenter, open-label study of the efficacy and immune response of GVAX pancreas vaccine and CRS-207 compared to chemotherapy or to CRS-207 alone in adults with previously treated metastatic pancreatic adenocarcinoma (ECLIPSE Study). F1000Posters 2015, 6:66 (poster)

A phase 2b, randomized, controlled, multicenter, open-label study of the efficacy and immune response of GVAX pancreas vaccine and CRS-207 compared to chemotherapy or to CRS-207 alone in adults with previously treated metastatic pancreatic adenocarcinoma (ECLIPSE Study)

Dung T Le1, Andrea Wang-Gillam, Vincent J Picozzi, Todd S Crocenzi, Michael Morse, Herbert Zeh III, Robert Lance Fine, Aimee Murphy, Justin Skoble, Ed Lemmens, Sandy Ferber, Allan Rosen, John J Grous, Thomas Dubensky Jr, Dirk G Brockstedt, Elizabeth M Jaffee
Published 19 Jan 2015
Author Affiliations
  • Metrics
  • 317 Views
  • 158 Downloads
 
Browse by related subjects
Published 19 Jan 2015

A phase 2b, randomized, controlled, multicenter, open-label study of the efficacy and immune response of GVAX pancreas vaccine and CRS-207 compared to chemotherapy or to CRS-207 alone in adults with previously treated metastatic pancreatic adenocarcinoma (ECLIPSE Study)

[version 1; not peer reviewed]

Dung T Le1, Andrea Wang-Gillam, Vincent J Picozzi, Todd S Crocenzi, Michael Morse, Herbert Zeh III, Robert Lance Fine, Aimee Murphy, Justin Skoble, Ed Lemmens, Sandy Ferber, Allan Rosen, John J Grous, Thomas Dubensky Jr, Dirk G Brockstedt, Elizabeth M Jaffee
Author Affiliations
1 The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, USA
Presented at
Society for Immunotherapy of Cancer (SITC) Meeting 2014
Abstract
Competing Interests

No competing interests were disclosed

Comments
0 Comments
 
Sign In
If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.

The email address should be the one you originally registered with F1000.

Email address not valid, please try again

You registered with F1000 via Google, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Google account password, please click here.

You registered with F1000 via Facebook, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Facebook account password, please click here.

Code not correct, please try again
Email us for further assistance.
Server error, please try again.